79 related articles for article (PubMed ID: 19863224)
41. Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer.
Nagorsen D; Thiel E
Clin Cancer Res; 2006 May; 12(10):3064-9. PubMed ID: 16707603
[TBL] [Abstract][Full Text] [Related]
42. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
[TBL] [Abstract][Full Text] [Related]
43. Levels of 25 cytokines in the first seven days of life in newborn infants.
Lusyati S; Hulzebos CV; Zandvoort J; Sauer PJ
BMC Res Notes; 2013 Dec; 6():547. PubMed ID: 24359685
[TBL] [Abstract][Full Text] [Related]
44. [Peptide vaccine treatment for colorectal cancer].
Okuno K
Nihon Rinsho; 2011 Apr; 69 Suppl 3():574-8. PubMed ID: 22214026
[No Abstract] [Full Text] [Related]
45. Immunological monitoring for prediction of clinical response to antitumor vaccine therapy.
Mikhaylova IN; Shubina IZ; Chkadua GZ; Petenko NN; Morozova LF; Burova OS; Beabelashvili RS; Parsunkova KA; Balatskaya NV; Chebanov DK; Pospelov VI; Nazarova VV; Vihrova AS; Cheremushkin EA; Molodyk AA; Kiselevsky MV; Demidov LV
Oncotarget; 2018 May; 9(36):24381-24390. PubMed ID: 29849947
[TBL] [Abstract][Full Text] [Related]
46. Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer.
Hardy-Werbin M; Rocha P; Arpi O; Taus Á; Nonell L; Durán X; Villanueva X; Joseph-Pietras D; Nolan L; Danson S; Griffiths R; Lopez-Botet M; Rovira A; Albanell J; Ottensmeier C; Arriola E
Oncoimmunology; 2019; 8(6):e1593810. PubMed ID: 31069160
[No Abstract] [Full Text] [Related]
47. Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
Leeman H; Kaminska E; Green D; Bodman-Smith M; Gravett A; Bodman-Smith K; Copier J; Coulton G; Fusi A; Dalgleish AG
Transl Oncol; 2019 Mar; 12(3):397-403. PubMed ID: 30530187
[TBL] [Abstract][Full Text] [Related]
48. Dendritic cell vaccination as a treatment modality for mesothelioma.
Gregoire M
Expert Rev Respir Med; 2010 Jun; 4(3):311-4. PubMed ID: 20524913
[No Abstract] [Full Text] [Related]
49. Dendritic cell vaccination of patients with metastatic colorectal cancer.
Burgdorf SK
Dan Med Bull; 2010 Sep; 57(9):B4171. PubMed ID: 20816019
[TBL] [Abstract][Full Text] [Related]
50. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis.
Ueda T; Shimada E; Urakawa T
J Gastroenterol; 1994 Aug; 29(4):423-9. PubMed ID: 7951851
[TBL] [Abstract][Full Text] [Related]
51. A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.
Morse MA; Niedzwiecki D; Marshall JL; Garrett C; Chang DZ; Aklilu M; Crocenzi TS; Cole DJ; Dessureault S; Hobeika AC; Osada T; Onaitis M; Clary BM; Hsu D; Devi GR; Bulusu A; Annechiarico RP; Chadaram V; Clay TM; Lyerly HK
Ann Surg; 2013 Dec; 258(6):879-86. PubMed ID: 23657083
[TBL] [Abstract][Full Text] [Related]
52. Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer.
Bridge JA; Lee JC; Daud A; Wells JW; Bluestone JA
Front Med (Lausanne); 2018; 5():351. PubMed ID: 30631766
[TBL] [Abstract][Full Text] [Related]
53. Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.
Abascal J; Oh MS; Liclican EL; Dubinett SM; Salehi-Rad R; Liu B
Cells; 2023 Oct; 12(19):. PubMed ID: 37830618
[TBL] [Abstract][Full Text] [Related]
54. Cancer/testis antigens: promising immunotherapy targets for digestive tract cancers.
Ai H; Yang H; Li L; Ma J; Liu K; Li Z
Front Immunol; 2023; 14():1190883. PubMed ID: 37398650
[TBL] [Abstract][Full Text] [Related]
55. A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.
Ura B; Capaci V; Aloisio M; Di Lorenzo G; Romano F; Ricci G; Monasta L
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009404
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches.
Gowhari Shabgah A; Amir A; Gardanova ZR; Olegovna Zekiy A; Thangavelu L; Ebrahimi Nik M; Ahmadi M; Gholizadeh Navashenaq J
Cancer Med; 2021 Aug; 10(15):5191-5202. PubMed ID: 34128588
[TBL] [Abstract][Full Text] [Related]
57. Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial.
Nistor GI; Dillman RO
J Transl Med; 2020 Apr; 18(1):176. PubMed ID: 32316978
[TBL] [Abstract][Full Text] [Related]
58. Cytokine and Cancer Biomarkers Detection: The Dawn of Electrochemical Paper-Based Biosensor.
Loo SW; Pui TS
Sensors (Basel); 2020 Mar; 20(7):. PubMed ID: 32230808
[TBL] [Abstract][Full Text] [Related]
59. LncRNA UCA1 promotes cell proliferation, invasion and migration of laryngeal squamous cell carcinoma cells by activating Wnt/β-catenin signaling pathway.
Sun S; Gong C; Yuan K
Exp Ther Med; 2019 Feb; 17(2):1182-1189. PubMed ID: 30679991
[TBL] [Abstract][Full Text] [Related]
60. Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).
Butterfield LH; Zhao F; Lee S; Tarhini AA; Margolin KA; White RL; Atkins MB; Cohen GI; Whiteside TL; Kirkwood JM; Lawson DH
Clin Cancer Res; 2017 Sep; 23(17):5034-5043. PubMed ID: 28536308
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
